शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BAJAJCONBSEBAJAJ CONSUMER CARE LTD· Personal ProductsHighNeutral
Announced Wed, 14 Oct, 2026 · 17:48 IST

Q2 FY27: Revenue up 26%, PAT up 71% YoY on restated basis

Revenue growth above 20%Profit growth above 25%Results restatedResults View source PDFExplain this filing

BAJAJCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-11.2%Reaction day
₹522.60
prior close
₹522.00
announcement price
After-mkt
timing
Nifty Microcap 250market-1.6%-9.6% vs market
Personal Care peers, median of 12sector-0.7%-10.5% vs sector

On the reaction day the stock moved 9.6 pts less than Nifty Microcap 250 and 10.5 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.5
10m
-3.2
15m
-3.8
30m
-5.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-11.2-1.6-9.6-0.7-10.5
Next day
-10.1-1.0-9.2-0.5-9.7
2d
-14.3-2.6-11.7-1.5-12.8
3d
-18.5-5.1-13.4-2.7-15.8
4d
-20.8-6.1-14.7-3.5-17.3
5d
-23.7-8.3-15.4-6.3-17.3
1w
-26.0-6.4-19.7-6.6-19.4
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Personal Care peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2 and H1 FY27 unaudited results. Standalone revenue from operations rose to Rs 66,183 lakh in H1 FY27 vs Rs 52,665 lakh YoY (up about 26%). Standalone PAT jumped to Rs 14,069 lakh vs Rs 8,239 lakh (up about 71%). Consolidated PAT stood at Rs 14,090 lakh. Figures are restated to reflect the Vishal Personal Care merger scheme effective May 2026. Mr. Jitendra Mahajan appointed as Independent Director after Mr. K.S. Narayanan resigned citing personal medical reasons.

Likely market impact

Strong revenue and profit growth on restated basis post VPCL merger. Director churn is a governance watchpoint but limited near-term impact.